Different angiotensin receptor blockers and incidence of diabetes: a nationwide population-based cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Different angiotensin receptor blockers and incidence of diabetes: a nationwide population-based cohort study

Published:2014-05-14 Issue:1 Volume:13 Page:
ISSN:1475-2840
Container-title:Cardiovascular Diabetology
language:en
Short-container-title:Cardiovasc Diabetol

Author:

Chang Chia-Hsuin,Chang Yi-Cheng,Wu Li-Chiu,Lin Jou-Wei,Chuang Lee-Ming,Lai Mei-Shu

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1186/1475-2840-13-91.pdf

Reference38 articles.

1. Scheen AJ: Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms. Diabetes Metab. 2004, 30 (6): 498-505. 10.1016/S1262-3636(07)70147-7.

2. Abuissa H, Jones PG, Marso SP, O’Keefe JH: Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 2005, 46 (5): 821-826. 10.1016/j.jacc.2005.05.051.

3. Elliott WJ, Meyer PM: Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet. 2007, 369 (9557): 201-207. 10.1016/S0140-6736(07)60108-1.

4. Jaques H: National Institure for Health and Clinical Excellence: NICE guideline on hypertension. Eur Heart J. 2013, 34 (6): 406-408.

5. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S, CHARM Investigators and Committees: Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-overall programme. Lancet. 2003, 362 (9386): 759-766. 10.1016/S0140-6736(03)14282-1.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypertension & dementia: Pathophysiology & potential utility of antihypertensives in reducing disease burden;Pharmacology & Therapeutics;2024-01

2. Long-term quality-of-care score for predicting the occurrence of acute myocardial infarction in patients with type 2 diabetes mellitus;World Journal of Diabetes;2023-07-15

3. Neuronal and Non-Neuronal GABA in COVID-19: Relevance for Psychiatry;Reports;2022-06-08

4. Hemmstoffe des Renin-Angiotensin-Systems;Arzneiverordnungs-Report 2021;2021

5. EFFECT OF OLMESARTAN ON PHARMACODYNAMICS AND PHARMACOKINETICS OF GLIMEPIRIDE AND METFORMIN COMBINATION IN ANIMAL MODELS;INDIAN DRUGS;2020-08-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3